Bullous Pemphigoid clinical trials

Explore recruiting bullous pemphigoid clinical trials.

Recruiting bullous pemphigoid studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bullous Pemphigoid trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid

France, Poland, Germany, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

An Open-label Extension Study of ARGX-113-2009 to Evaluate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

Bulgaria, Italy, Czechia, Spain, Hungary, Slovakia +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

DERMOS study : Influence of dermocorticoids on bone mineral density in patients with bullous pemphigoid.

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

Czechia, Italy, Spain, Hungary, Slovakia, Bulgaria +8 more

Phase II and Phase III (Integrated) EU CTIS Study details

Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial)

Spain, Poland, Hungary, Bulgaria, Italy, Netherlands +8 more

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)

France, Czechia, Portugal, Netherlands, Croatia, Hungary +8 more